// App-Quantinova.ai

EP514 : INFECTION-RELATED MORBIDITY AND MORTALITY FOR ELDERLY DLBCL PATIENTS TREATED WITH FULL OR ATTENUATED DOSE R-CHOP

Researchers

Presenter

  • Toby Eyre

Principal Investigators

  • William Wilson

  • Amy Kirkwood

  • Julia Wolf

  • Catherine Hildyard

  • Hannah Plaschkes

  • John Griffith

  • Paul Fields

  • Arief Gunawan

  • Rebecca Oliver

  • Stephen Booth

  • Jaimal Kothari

  • Christopher Fox

  • Nicolas Martinez-Calle

  • Andrew McMillan

  • Mark Bishton

  • Graham Collins

  • Chris Hatton

Medical Centers

  • Histopathology, Guys and St Thomas Hospitals NHS Foundation Trust, London, United Kingdom

  • Oxford University Hospitals NHS Trust, Oxford, United Kingdom

  • Department of Haematology, Milton Keynes Hospital, Milton Keynes, United Kingdom

  • University Hospitals Bristol NHS Foundation Trust, Wells Somerset, United Kingdom

  • Cancer Research UK &a

  • Haematology,GreatWestern Hospital,Swindon,United Kingdom

  • Nottingham University City Hospital NHS Trust, Nottingham, United Kingdom

  • UCL Cancer Trials Centre,UCL Cancer Institute,London,United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Doxorubicin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A